Analystreport

CASI Pharmaceuticals Inc (NASDAQ: CASI) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating.

CASI Pharmaceuticals, Inc. - Ordinary Shares  (CASI) 
Last casi pharmaceuticals, inc. - ordinary shares earnings: 11/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: casipharmaceuticals.com/investor-relations